BioLineRx (NASDAQ:BLRX) Price Target Raised to $26.00
BioLineRx (NASDAQ:BLRX – Get Free Report) had its target price increased by investment analysts at HC Wainwright from $9.00 to $26.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Separately, StockNews.com cut BioLineRx from a “hold” rating to a “sell” rating in […]
BioLineRx (NASDAQ:BLRX – Get Free Report) had its target price increased by investment analysts at HC Wainwright from $9.00 to $26.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Separately, StockNews.com cut BioLineRx from a “hold” rating to a “sell” rating in […]
